TPI is a privately held pharmaceutical company specializing in the development and production of bioactive peptides, peptide derivatives and the technology for their transdermal delivery. One of the most extensive dermally related development programs in the industry allows TPI to offer its clients a diverse array of dermally bioactive peptides and lipopeptides in various carriers. These peptidics can be purchased in bulk, in a low toxicity solvent carrier or an appropriate nanoemulsion for the cosmoseutical or pharmaceutical formulator to incorporate into aqueous, emulsion or anhydrous product types.